This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Japan, Lithuania, Poland, Romania
The drug VOXZOGO contains one active pharmaceutical ingredient (API):
|
1
Vosoritide
UNII 7SE5582Q2P - VOSORITIDE
|
|
Vosoritide is a modified type C natriuretic peptide (CNP). In patients with achondroplasia, endochondral bone growth is negatively regulated due to a gain of function mutation in fibroblast growth factor receptor 3 (FGFR3). Binding of vosoritide to natriuretic peptide receptor-B (NPR-B) antagonises FGFR3 downstream signalling by inhibiting the extracellular signal-regulated kinases 1 and 2 (ERK1/2) in the mitogen-activated protein kinase (MAPK) pathway at the level of rapidly accelerating fibrosarcoma serine/threonine protein kinase (RAF-1). As a result, vosoritide, like CNP, acts as a positive regulator of endochondral bone growth as it promotes chondrocyte proliferation and differentiation. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| VOXZOGO Powder and solvent for solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M05BX07 | M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BX Other drugs affecting bone structure and mineralization | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1861152, 1861163, 1861174 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1211577001, 1211577002, 1211577003 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60787186, 64530919, 68092884 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 049692015, 049692027, 049692039 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3999465D1028, 3999465D2024, 3999465D3020 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1093281, 1093282, 1093283 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100457685, 100457692, 100457712 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68898001, W68899001, W68900001 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
